Indian pharma cos want Chinese imports tested
Worried by the spread of deadly COVID-19, pharma companies have asked the government to set up a mechanism under which imports of raw materials (active...
Continue ReadingGUBBA PHARMA IN E NEWS
First antiviral drug approved to fight coronavirus
Favilavir, formerly known as Fapilavir, an antiviral that has shown efficacy in treating the novel coronavirus, was approved for marketing, the Taizhou government in Zhejiang...
Continue Reading
JB Chemicals Gujarat unit passes USFDA inspection with one observation
JB Chemicals and Pharmaceuticals said its Gujarat unit has passed the US health regulator’s periodical inspection with one minor procedural observation. The company’s solid oral...
Continue Reading
Coronavirus: DGCI approves ‘restricted use’ of anti-HIV drugs on nCoV patients
• ICMR had sought an emergency approval from the DCGI for the ‘restricted use’ of the combination of 2 medications — lopinavir and ritonavir —...
Continue Reading
Coronavirus outbreak: China shutdown to hit Indian drug manufacturers
Indian drug manufacturers are to a large extent dependent on China for sourcing their drug ingredients or the active pharmaceutical ingredients, as the industry words...
Continue Reading
Pharma exports post highest-ever growth in third-quarter at 14.6%
Total exports on course to touch $22 billion by March, says Pharmexcil Bucking recessionary trends, pharmaceutical exports registered highest-ever growth in the third quarter ended...
Continue Reading
Cipla, PAG eye Wockhardt’s formulations business
Cipla and Asian buyout fund PAG are vying with each other to acquire a big chunk of Wockhardt’s domestic formulations business for Rs 2,100-2,800 crore...
Continue Reading
Artificial intelligence-created medicine to be used on humans for first time
A drug molecule “invented” by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine. It was...
Continue Reading
Merck, Bayer, AstraZeneca, Pfizer – How 22 companies became 4 MNC’s
Source : https://www.linkedin.com/in/andrew-p/
Continue Reading
